How much funding has STINGINN, LLC raised?

STINGINN, LLC has raised $2.4M in total funding, most recently a Grant round.

Who are STINGINN, LLC's investors?

STINGINN, LLC's investors include National Institutes of Health.

When was STINGINN, LLC founded?

STINGINN, LLC was founded in 2020.

Where is STINGINN, LLC headquartered?

STINGINN, LLC is headquartered in Miami, Florida, United States.

What industry is STINGINN, LLC in?

STINGINN, LLC operates in Biotech, Healthcare, Oncology.

How many employees does STINGINN, LLC have?

STINGINN, LLC has 1-10 employees.

STINGINN, LLC

Harnessing the innate immune system to combat infectious disease, inflammation, and cancer

Miami, United States · Founded 2020 · $2.4M raised

Biotech

Healthcare

Oncology

Headquarters: Miami, Florida
Employees: 1–10
Founded: 2020
Business Model: B2B

Website: stinginn.com
Total Funding: $2.4M
Last Round: $400K GrantJul 2023
Rounds: 2

About

StingInn LLC is a clinical-stage biotechnology company harnessing the innate immune system to combat infectious disease, inflammation, and cancer. The company's pipeline is built around the STING (stimulator of interferon genes) signaling pathway, with therapeutics including STING activators (STAVs) for anti-tumor immunotherapy, STING inhibitors for autoimmune and inflammatory disease, and an HTLV-1 vaccine. StingInn has received FDA approval to initiate Phase I clinical trials for leukemia treatment.

Summary

STINGINN, LLC is a Biotech company based in Miami, United States, founded in 2020. It has raised $2.4M in total across 2 rounds, most recently a $400K Grant round in Jul 2023. Investors include National Institutes of Health.